Isolated Immune Cells
Isolated immune cells play a crucial role across the stages of drug discovery and development from biomarker and target identification through screening and safety assessment to manufacturing. They can be used to create disease models, cell lines, gene editing techniques and more.
Isolated Immune Cells and Subsets
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Isolated immune cells play a crucial role across the stages of drug discovery and development from biomarker and target identification through screening and safety assessment to manufacturing. They can be used to create disease models, cell lines, gene editing techniques and more.
BioIVT provides high quality isolated cells, ethically sourced from a diverse pool of human donors or any commercially available animal model. BioIVT offers custom procurement or extensive inventory of:
- RUO & GMP Leukopaks – Industry-standard leukapheresis starting material
- Purified CD34+ HSCs & CD3+ Pan T cells – Save time on isolation with ready-to-ship cryopreserved cells
- Cytotoxic, Naïve and Memory T cell subsets – The rare cell types you need at guaranteed yields
- PBMCs, BMMCs, Monocytes, B Cells, NK Cells, Basophils, Eosinophils, Neutrophils, and more
BioIVT also provides RUO- and GMP-grade human AB serum to maximize your cell expansion.
TechTalk: Crucial Starting Material Considerations for NAM Success
Friday, September 25 at 16:00 BST | 17:00 CEST | 11:00 EDT | 08:00 PDT
With industry and regulatory leaders placing greater emphasis on New Approach Methodologies (NAMs), researchers need starting materials that support human relevance, reproducibility, and confidence from the outset.
In this 20-minute SelectScience® TechTalk, Dr. Courtney Noah, Vice President of Scientific Affairs at BioIVT, will explore how ethically sourced and well-characterized human specimens can influence the success of NAM development.
The session will examine how donor variability, fit-for-purpose quality control, standardization, and documentation can help researchers generate more reliable nonclinical data and de-risk NAM workflows from the start.
Certificate of attendance
If you attend the live TechTalk, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes. If you view the on-demand TechTalk, you can request a certificate of attendance by emailing editor@selectscience.net.
TechTalk details
- Cost: Free to attend
- Location: Online
- Duration: 20 minutes
Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on-demand recording once it becomes available.
Modeling immune related adverse events in preclinical research
In this guest editorial, Dr. Courtney Noah, BioIVT's Vice President of Scientific Affairs, explores why disease state donors and purified immune subsets improve predictive safety models
